Nodus oncology is developing first and best-in-class molecules inhibiting novel targets within the DNA damage response and replication stress response.Supported by most recent scientific advances, we are developing the next wave of cancer therapeutics in the DNA damage response (DDR) area.Founded by Cumulus Oncology and in partnership with the Lead discovery Center, Nodus Oncology is developing an innovative portfolio focused on synthetic lethality and collateral vulnerabilities in molecularly defined cancer patient populations

Nodus Oncology

Euro

Microsoft Exchange Online

Office 365 Mail

Microsoft Azure DNS

GoDaddy DNS

Krystal Hosting

Bert Klebl

Europe, Middle East, and Africa (EMEA) Startups (Top 10K)

Europe Companies With Fewer Than 1000 Employees (Top 10K)

Oncology Companies with Seed Funding

Kent Companies With Fewer Than 1000 Employees

Nodus Oncology Developing the DDR targeting therapies.

KHAN Technology Transfer Fund

Seed Round - Nodus Oncology

Snodland

Kent

United Kingdom

Europe

PARG inhibitor from Nodus Oncology has in vivo activity

Nodus Oncology on LinkedIn: #aacr2024 #science #parginhibitors

Edinburgh BioTech Nodus Oncology Secures £2.4m Funding

Nodus Oncology focuses on developing therapies that target DNA Damage Response (DDR) mechanisms to treat cancer.

Nodus Oncology is a biotech company developing first and best-in-class molecules focused on the DNA damage response (DDR) in patient sub-groups where molecular vulnerabilities exist. Founded by Cumulus Oncology and in partnership with the Lead Discovery Center, Nodus Oncology is developing an innovative portfolio focused on synthetic lethality and collateral vulnerabilities in molecularly defined cancer patient populations.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	1e7bc6fe
crunchbase profile	general	Nov 27, 2024 1:21 PM	8b75658c
li profile	general	Feb 6, 2024 8:09 AM	736b8e40
translate crunchbase fundingrounds	general	Nov 27, 2024 2:59 PM	5a410db5
peers	general	Feb 6, 2024 8:09 AM	c972f5d6
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:NODUSONCOLOGY

Nodus Oncology